Nexavar looks on track to steal any market share they would have had if the drug showed statistical efficacy. Be prepared for a brutal fall below $1.Nexavar is 18 months ahead of PI-88, now.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor